New CBD-Based Drug Offers Hope For Breast Cancer Patients Struggling With Pain: Clinical Trial Kicks Off
Posted
Jelena Martinovic (via Benzinga)
City of Hope & BRC launch a clinical trial testing BRC-001, a CBD-based therapy for breast cancer patients with joint pain caused by hormone treatments.
read more
arthralgia,
Biopharmaceutical Research Company,
BRC-001,
cannabinoid therapy,
Cannabis,
cannabis breast cancer,
cannabis cancer,
CCC,
City of Hope,
George Hodgin,
Lisa Yee,
News,
Health Care,
News,
Cannabis,
Health Care,
Benzinga
